Delivery Order SPE2DB24D9131-SPE2DB24FXRN8
- Not listed
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,339.18 contract was awarded by the Defense Logistics Agency (DLA) to provide 120 tablets of the medication XTANDI 40 MG. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program to supply a wide range of pharmaceutical products, including both common...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $33,356.72 contract is for the delivery of a specific pharmaceutical product - XTANDI 80 MG TABLET 60S. The order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, that runs through December 31, 2025. This...
- This is a $4,169.59 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for 4567128650 - XTANDI 80 MG TABLET 60S, a prescription medication, with a period of performance through February 3, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,339.18 contract is for the delivery of XTANDI 40 MG TABLET 120S, a specialized pharmaceutical product. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,311.35 order is for 120 capsules of the prescription drug XTANDI 40 MG. The order is part of a larger $499,999,999 indefinite-delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,169.59 order is for XTANDI 40 MG TABLET 120S and is part of a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,508.77 contract is for the supply of XTANDI 80 MG TABLET 60S, a specialized pharmaceutical product. This delivery order is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, which provides a comprehensive range of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $8,339.18, is for the supply of 4,563,963,231 units of XTANDI 80 MG TABLET 60S for a period ending on March 14, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,508.77 contract is for the delivery of XTANDI 80 MG TABLET 60S, a prescription medication. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) the DLA has with DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical products,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with an award ceiling value of $8,622.70, is for the delivery of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product. The delivery order was issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to...
- SPE2DB24D9131Indefinite Delivery Contract
- SPE2DB24D9131-SPE2DB24FXRN8Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,339.18 order is for 60 tablets of the prescription drug XTANDI 80 MG. The order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that allows the DLA to issue delivery orders for a wide range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The IDC, which runs through December 31, 2025, does not have a set-aside designation. Through this and other prime vendor contracts, DMS Pharmaceutical Group provides a vast array of medications, including both common and specialized pharmaceutical products, to the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 7/15/24 |